# Validation of RCC Predicting Model With Emulated-target Trial

> **NCT07117227** · — · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 4700 (estimated)

## Conditions studied

- Renal Cell Carcinoma (Kidney Cancer)
- Renal Cell Carcinoma (RCC)
- Tumor Thrombus
- Prognosis
- Prognostic Cancer Model
- Real World Study
- Observational Study

## Interventions

- **PROCEDURE:** Model-guided adjuvant treatment
- **PROCEDURE:** No adjuvant treatment

## Key facts

- **NCT ID:** NCT07117227
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 4700 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07117227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07117227, "Validation of RCC Predicting Model With Emulated-target Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07117227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*